NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
September 19, 2025 — Insilico Medicine CEO Alex Zhavoronkov reveals how AI is revolutionizing drug discovery, compressing development timelines and advancing Pharmaceutical Superintelligence with clinical breakthroughs.
September 19, 2025 — Lexaria Bioscience's DehydraTECH enhances brain delivery of GLP-1 drugs, improving safety and efficacy in rodent studies. Potential breakthrough for weight loss and diabetes treatments.
September 19, 2025 — ABVC BioPharma reports $1.28M Q3 licensing revenue from OncoX and other partners, strengthening cash position and high-margin business model in biopharmaceutical sector.
September 19, 2025 — Creative Biolabs drives CAR-T therapy innovation with one-stop development platform, viral vector plasmids, and GMP-grade vectors for cancer research and clinical applications.
September 19, 2025 — Creative Biolabs introduces advanced protein-level detection and combined nucleic acid-protein biomarker services for early disease diagnosis in cancer, neurodegenerative and infectious diseases.
September 18, 2025 — Viromed Medical AG receives ISO 13485 certification, enabling market launch of ViroCAP® cold plasma devices for dermatology and wound care in October 2025.
September 18, 2025 — Alzheimer's Community Care announces new funding covering day center attendance for 58 dementia patients in Florida. Specialized care includes therapy programs and caregiver respite services.
September 18, 2025 — Beachway Therapy Center hosts panel on trauma recovery book 'Rescued' by Tricia Youngs. Free event with expert insights on healing from abuse and addiction.
September 18, 2025 — CNSide Diagnostics receives CMS accreditation for its Houston lab, enabling broader patient access to advanced CSF testing for central nervous system cancer detection and management.
September 18, 2025 — McKesson announces new organizational structure to boost growth in oncology and biopharma services, enhancing transparency and shareholder value. Learn more at McKesson.com.
September 18, 2025 — Lantern Pharma completes Japan enrollment for Phase 2 NSCLC trial using AI platform. AI-driven drug development accelerates cancer treatment options for never-smoker patients.
September 18, 2025 — Streamline Scientific launches enhanced PCR reporting for UTI testing, integrating CLSI guidelines to reduce inappropriate antibiotic use and combat antimicrobial resistance through smarter diagnostics.
September 18, 2025 — University of Michigan study reveals dietary changes could make glioblastoma more responsive to chemotherapy and radiation treatments, offering new hope for brain cancer patients.
September 18, 2025 — American Heart Association awards scholarships to five high school students leading heart health initiatives. Learn how youth are combating cardiovascular risks through the American Heart Challenge program.
September 18, 2025 — Oncotelic Therapeutics featured in NetworkNewsWire for AI-driven cancer research targeting glioblastoma & pancreatic cancer. Clinical-stage biopharma with 500+ patents advancing transformative treatments.
September 18, 2025 — Kairos Pharma's ENV105 shows 13+ month survival in prostate cancer trial, exceeding targets with no toxicities. Breakthrough treatment addresses drug resistance.
September 18, 2025 — Quantum BioPharma receives Health Canada license for Qlarity natural health product, expanding access to energy, cognitive support, and fatigue reduction solutions in Canadian market.
September 18, 2025 — Maryland faces ACA health cost spikes, judicial accountability debates, offshore wind uncertainty, and election law concerns affecting residents' healthcare and safety.
September 18, 2025 — ADAP Advocacy exposes how the $66B 340B Drug Pricing Program fails patients despite growth, with hospitals pursuing aggressive medical debt collection against vulnerable Americans.
September 18, 2025 — Susan Simons' Under the Shield redefines PTSD as injury, not disorder for first responders. Watch the Innovators' Journey segment on mental wellness innovation.